Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 3
2013 2
2014 1
2015 5
2016 10
2017 5
2018 10
2019 8
2020 12
2021 22
2022 20
2023 26
2024 38
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
Mahé I, Carrier M, Mayeur D, Chidiac J, Vicaut E, Falvo N, Sanchez O, Grange C, Monreal M, López-Núñez JJ, Otero-Candelera R, Le Gal G, Yeo E, Righini M, Robert-Ebadi H, Huisman MV, Klok FA, Westerweel P, Agnelli G, Becattini C, Bamias A, Syrigos K, Szmit S, Torbicki A, Verhamme P, Maraveyas A, Cohen AT, Ay C, Chapelle C, Meyer G, Couturaud F, Mismetti P, Girard P, Bertoletti L, Laporte S; API-CAT Investigators. Mahé I, et al. N Engl J Med. 2025 Apr 10;392(14):1363-1373. doi: 10.1056/NEJMoa2416112. Epub 2025 Mar 29. N Engl J Med. 2025. PMID: 40162636 Clinical Trial.
[Aortitis].
Espitia O, Toquet C, Jamet B, Serfaty JM, Agard C. Espitia O, et al. Rev Med Interne. 2024 Dec;45(12):767-775. doi: 10.1016/j.revmed.2024.06.015. Epub 2024 Jul 20. Rev Med Interne. 2024. PMID: 39034261 Free article. Review. French.
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.
Couturaud F, Schmidt J, Sanchez O, Ballerie A, Sevestre MA, Meneveau N, Bertoletti L, Connault J, Benhamou Y, Constans J, Quemeneur T, Lapébie FX, Pernod G, Picart G, Elias A, Doutrelon C, Neveux C, Khider L, Roy PM, Zuily S, Falvo N, Lacroix P, Emmerich J, Mahé I, Boileau J, Yaici A, Le Jeune S, Stéphan D, Plissonneau-Duquene P, Ray V, des Déserts MD, Belhadj-Chaidi R, Lamia B, Gruel Y, Presles E, Girard P, Tromeur C, Moustafa F, Rothstein V, Lacut K, Melac S, Barillot S, Mismetti P, Laporte S, Mottier D, Meyer G, Leroyer C; RENOVE Investigators. Couturaud F, et al. Lancet. 2025 Mar 1;405(10480):725-735. doi: 10.1016/S0140-6736(24)02842-3. Lancet. 2025. PMID: 40023651 Free article. Clinical Trial.
[Takayasu's arteritis].
F Guédon A, Bourgade R, Elhannani M, Toquet C, Espitia O, Fain O, Mekinian A. F Guédon A, et al. Among authors: espitia o. Rev Prat. 2023 Apr;73(4):400-405. Rev Prat. 2023. PMID: 37289153 French.
[Gastrointestinal tract involvement in systemic sclerosis].
Renaud A, Jirka A, Durant C, Connault J, Espitia O, Takoudju C, Agard C. Renaud A, et al. Among authors: espitia o. Rev Med Interne. 2023 Aug;44(8):410-422. doi: 10.1016/j.revmed.2023.05.003. Epub 2023 Jun 1. Rev Med Interne. 2023. PMID: 37270380 Review. French.
[Giant cell arteritis].
Agard C, de Mornac D, Espitia O. Agard C, et al. Among authors: espitia o. Rev Prat. 2020 Oct;70(8):e281-e293. Rev Prat. 2020. PMID: 33739707 French. No abstract available.
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.
Mekinian A, Biard L, Lorenzo D, Novikov PI, Salvarani C, Espitia O, Sciascia S, Michaud M, Lambert M, Hernández-Rodríguez J, Schleinitz N, Awisat A, Puechal X, Aouba A, Munoz Pons H, Smitienko I, Gaultier JB, Edwige LM, Benhamou Y, Perlat A, Jego P, Goulenok T, Sacre K, Lioger B, Hassold N, Broner J, Dufrost V, Sené T, Seguier J, Maurier F, Berthier S, Belot A, Frikha F, Denis G, Audemard-Verger A, Koné-Paut I, Humbert S, Woaye-Hune P, Tomelleri A, Baldissera EM, Kuwana M, Lo Gullo A, Mukuchyan V, Dellal A, Gaches F, Zeminsky P, Galli E, Alvarado M, Boiardi L, Muratore F, Vautier M, Campochiaro C, Moiseev S, Vieira M, Cacoub P, Fain O, Saadoun D; French Takayasu network. Mekinian A, et al. Among authors: espitia o. RMD Open. 2023 Jun;9(2):e002830. doi: 10.1136/rmdopen-2022-002830. RMD Open. 2023. PMID: 37321669 Free PMC article.
Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis.
Guédon AF, Carrat F, Mouthon L, Launay D, Chaigne B, Pugnet G, Lega JC, Hot A, Cottin V, Agard C, Allanore Y, Fauchais AL, Lescoat A, Dhote R, Papo T, Chatelus E, Bonnotte B, Kahn JE, Diot E, Aouba A, Magy-Bertrand N, Queyrel V, Le Quellec A, Kieffer P, Amoura Z, Granel B, Gaultier JB, Balquet MH, Wahl D, Lidove O, Espitia O, Cohen A, Fain O, Hachulla E, Mekinian A, Rivière S. Guédon AF, et al. Among authors: espitia o. RMD Open. 2024 Dec 9;10(4):e004918. doi: 10.1136/rmdopen-2024-004918. RMD Open. 2024. PMID: 39658051 Free PMC article.
The prognostic value of blood cellular indices in pulmonary embolism.
Siddiqui F, Tafur A, Hussain M, García-Ortega A, Darki A, Fareed J, Jiménez D, Bikdeli B, Galeano-Valle F, Fernández-Reyes JL, Pérez-Pinar M, Monreal M; RIETE Investigators. Siddiqui F, et al. Am J Hematol. 2024 Sep;99(9):1704-1711. doi: 10.1002/ajh.27379. Epub 2024 May 30. Am J Hematol. 2024. PMID: 38816957 Free article.
162 results